Sunday January 19, 2020 16:13

Heathcare Press Release : 10 Sep 2019

Updated Results for Investigational Therapy Tepotinib Presented at WCLC Heathcare—10 Sep 19

- Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study - Phase II INSIGHT 2 study now open for enrollment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal